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NF-κBhe HTLV-1 Tax protein involves activation of the NF-κB pathway, which depends
on Tax phosphorylation, ubiquitination and sumoylation. We demonstrate that the nuclei of Tax-expressing
cells, including HTLV-1 transformed T-lymphocytes, contain a pool of Tax molecules acetylated on lysine
residue at amino acid position 346 by the transcriptional coactivator p300. Phosphorylation of Tax on serine
residues 300/301 was a prerequisite for Tax localization in the nucleus and correlated with its subsequent
acetylation by p300, whereas sumoylation, resulting in the formation of Tax nuclear bodies in which p300
was recruited, favored Tax acetylation. Overexpression of p300 markedly increased Tax acetylation and the
ability of a wild type HTLV-1 provirus, –but not of a mutant provirus carrying an acetylation deﬁcient Tax
gene–, to activate gene expression from an integrated NF-κB-controlled promoter. Thus, Tax acetylation
favors NF-κB activation and might play an important role in HTLV-1-induced cell transformation.
© 2009 Elsevier Inc. All rights reserved.IntroductionThe human T-cell leukemia virus type 1 (HTLV-1) is the etiological
agent of adult T-cell leukemia (ATL) and a virus-associated neurode-
generative disease, HTLV-1-associated myelopathy (HAM)/tropical
spastic paraparesis (TSP) (Yoshida et al., 1984; Osame et al., 1986;
Poiesz et al., 1980). These diseases have been linked to the expression
of the HTLV-1 regulatory protein, Tax (Tanaka et al., 1990; Franchini,
1995; Grassmann et al., 1992; Nerenberg et al., 1987). Tax is a
pleiotropic transcription factor, which activates gene expression by
assembling complexes including cellular transcription factors and
coactivators at the HTLV-1 promoter and at promoters of various
cellular genes involved in T-lymphocyte proliferation. Tax interacts
with members of the ATF/CREB family of cellular transcription factors
and increases their binding afﬁnity to the enhancer sequence made of
three 21-bp repeats present in the HTLV-1 5′ LTR. Formation of this
complex leads to the recruitment of the transcriptional coactivator
cAMP response element-binding protein (CBP), leading to the
activation of viral gene expression (Giebler et al., 1997; Harrod et al.,
1998; Jiang et al., 1999; Kwok et al., 1996).iologie Structurale, UMR 5089
l rights reserved.Leukemogenesis induced by HTLV-1 has been linked to the ability
of Tax to constitutively activate the NF-κB pathway (Huang et al.,
2000; Malek et al., 2001; Chu et al., 1999; Harhaj and Sun, 1999;
Yamamoto and Gaynor, 2004; Kehn et al., 2004; Ratner et al., 2000), to
inhibit DNA repair processes (Jeang et al., 2004; Marriott and Semmes,
2005; Haoudi et al., 2003) and to inactivate the p53 tumor suppressor
(Jeong et al., 2005; Ariumi et al., 2000). In addition, Tax affects cell
cycle progression by acting at multiple levels including direct
interactionwith cyclin-dependent kinases and their inhibitors leading
to Rb hyperphosphorylation (Neuveut and Jeang, 2000; Kehn et al.,
2005; Haller et al., 2002; Suzuki et al., 1996), centrosome ampliﬁcation
and subversion of the mitotic spindle assembly checkpoint (Pumfery
et al., 2006; Kasai et al., 2002) and promotion of S-phase entry
togetherwith a block inmitosis (Liang et al., 2002; Liu et al., 2005; Kuo
and Giam, 2006; Sibon et al., 2006).
Tax undergoes post-translational modiﬁcations including phos-
phorylation, ubiquitination and sumoylation (Peloponese et al., 2004;
Lamsoul et al., 2005; Shembade et al., 2007; Bex et al., 1999; Nasr et al.,
2006). Tax phosphorylation at serine residues 300 and/or 301 is
critical for Tax-mediated activation of gene expression via both the
ATF/CREB and NF-κB pathways (Bex et al., 1999; Durkin et al., 2006).
Ubiquitination of Tax leads to its cytoplasmic retention and this
modiﬁcation is critical for the activation of the IKK complexes,
resulting in RelA translocation to the nucleus (Lamsoul et al., 2005;
Nasr et al., 2006; Yu et al., 2008). However, these cytoplasmic events
are not sufﬁcient for Tax activation of the NF-κB pathway. In addition,
Fig. 1. Tax is acetylated on the lysine residue at amino acid position 346. (A) Schematic
representation of the Tax protein with the positions of the lysines replaced by arginine
residues in the different Tax mutants. (B) 293T cells were transfected with vectors
expressing wild type or mutant Tax-6His. The cell extracts were puriﬁed by Ni-NTA
pulldown followed by Western blotting with the anti-Tax rabbit polyclonal (α-Tax) or
the anti-acetyllysine mouse monoclonal (α-Ac) antibodies. (C) 293T cells were
transfected with vectors expressing wild type or K10R Tax-6His in the absence or the
presence of a vector expressing either HA-SUMO-1 (HA-S1) or HA-Ubiquitin (HA-Ub).
The cell extracts were puriﬁed by Ni-NTA pulldown followed by Western blotting with
anti-Tax, anti-acetyllysine or anti-HA antibodies for the detection of HA-SUMO-1 or HA-
Ubiquitin. (D) Cell extracts from CEM T-lymphocytes transfected or not with a vector
expressing wild type Tax-6His puriﬁed by Ni-NTA pulldown or cell extracts from HTLV-
1 infected T-lymphocytes C8166 or HUT102 were immunoblotted with anti-Tax or anti-
acetyllysine antibodies. The arrow points to the acetylated form of Tax detected in
HTLV-1 transformed T-lymphocytes. (E) 293T cells transfected or not with a vector
expressing wild type Tax-6His were fractionated into the cytoplasmic (Cy) and nuclear
(Nu) fractions, puriﬁed by Ni-NTA pulldown and immunoblotted with anti-Tax or anti-
acetyllysine antibodies. The total fractions were also immunoblotted with anti-IKKβ or
anti-hnRNP A1 antibodies as controls for the purity of the cytoplasmic and nuclear
fractions, respectively.
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retention and the formation of nuclear bodies that include transcrip-
tion factors such as the NF-κB subunits p50 and RelA, the transcrip-
tional coactivators p300 and CBP as well as components of the
transcription and the splicingmachineries (Bex et al., 1998). Thus, both
ubiquitination and sumoylation act in concert for Tax-mediated
activation of gene expression via the NF-κB pathway.
Acetylation is a fourth post-translational modiﬁcation which
modulates transcription factor properties including their DNA binding
afﬁnity, their stability and their ability to interactwith coactivators and
corepressors (Glozak et al., 2005; Calao et al., 2008). This modiﬁcation
may also compete with ubiquitination or sumoylation for overlapping
targeted lysine residues. We thus analyzed whether Tax was
acetylated. In this work, we demonstrate that the transcriptional
coactivator p300 acetylates the lysine residue at amino acid position
346 in the carboxy-terminal domain of Tax and that this modiﬁcation
favors activation of gene expression via the NF-κB pathway, suggesting
that the Tax oncogenic potential depends on Tax acetylation.
Results
Tax is acetylated on the lysine residue at amino acid position 346
To test whether Tax was modiﬁed by acetylation, 293T cells were
transfected with a vector expressing 6His-tagged wild type Tax (Tax-
6His) or Tax-6His mutants that had either all (K1-10R) or only some
(K9R, K9-10R and K10R) of the ten lysine residues of Tax substituted by
arginines. The schematic representation of these mutants is presented
in Fig. 1A. Following transfection, cells were lysed in highly denaturing
conditions in the presence of deacetylase inhibitors to prevent
demodiﬁcation. The cell extracts were subjected to Ni-NTA pulldown
and the puriﬁed proteins were analyzed by immunoblotting with a
rabbit polyclonal antibody directed against Tax (α-Tax) or a mono-
clonal antibody directed against acetyllysine (α-Ac) (Fig. 1B).
Expression of Tax caused the appearance of a 40 kDa species, which
was recognized by the anti-acetyllysine antibody and comigrated with
the 40 kDa Tax species recognized by the anti-Tax antibody. This species
was not detected in cells that did not express Tax or in cells expressing
mutants that had at least K10 mutated (K1-10R, K10R and K9-10R),
whereas mutant K9R was acetylated like wild type Tax. These results
indicated that Tax was acetylated and strongly suggested that lysine K10
at amino acid position 346 was the target for this modiﬁcation. As
expected from the mutation of all 10 lysines, no Tax species of molecular
mass higher than 40 kDa previously attributed to ubiquitinated and
sumoylated Tax molecules (Lamsoul et al., 2005) were detected in cells
expressing the K1–10Rmutant. By contrast, the ladder of slowmigrating
forms of Tax was detected in cells expressing the acetylation deﬁcient
K9–10R and K10R mutants, suggesting that the defect of Tax acetylation
did not alter its ability to be ubiquitinated or sumoylated. Thiswas clearly
evidencedbyanalyzing the sumoylation andubiquitination status ofwild
type Tax or the K10R mutant by Ni-NTA pulldown of 293T cells
coexpressing either HA-SUMO-1 (HA-S1) or HA-Ub (Fig. 1C), indicating
that the acetylation deﬁcient K10R mutant was sumoylated and
ubiquitinated. The presence of non-speciﬁc bands recognized by the
anti-acetyllysine antibody (Fig. 1C, α-Ac) prevented the detection of Tax
species ofmolecularweight higher than55kDa thatwere both acetylated
and sumoylated or ubiquitinated. The question whether sumoylated
forms of Tax can be acetylated will be discussed further below.
We then checked whether Tax was acetylated in T-lymphocytes,
the physiological host of HTLV-1, as well as in HTLV-1 transformed T-
lymphocytes. CEM T-lymphocytes transfected or not with a vector
expressing Tax-6His or HTLV-1-transformed T-lymphocyte cell lines
C8166 or HUT102 were lysed in highly denaturating conditions and
the cell extracts were immunoblotted with anti-Tax or anti-acetylly-
sine antibodies (Fig. 1D). The acetylated form of Tax was detected in
CEM cells overexpressing Tax-6His and endogenous Tax expressed inHTLV-1 transformed T-lymphocytes was also acetylated. The lack of a
6His tag on endogenous Tax expressed by the HTLV-1 transformed cell
lines prevented its puriﬁcation by Ni-NTA pulldown, which explains
the higher background and the fainter acetylated Tax species on the
anti-acetyllysine immunoblot. We were unable to detect the acety-
lated form of Tax in HTLV-1-transformed T-lymphocyte cell lines
following immunoprecipitation. We suspect that acetylation at lysine
70 J. Lodewick et al. / Virology 386 (2009) 68–78K346, which is part the Tax immunodominant epitope (K346HFRE-
TEV353) (Levin et al., 2002) partly masks this epitope from recognition
by anti-Tax antibodies.
Fractionation of Tax-expressing 293T cells was then used to
determine the intracellular localization of the acetylated form of
Tax. 293T cells were transfected with a vector expressing wild type
Tax-6His or with the empty vector as a control. The cell extracts were
fractionated into cytoplasmic and nuclear extracts, which were
submitted to Ni-NTA pulldown. The puriﬁed proteins were analyzed
by immunoblotting using anti-Tax or anti-acetyllysine antibodies as
well as anti-hnRNP A1 and anti-IKKβ antibodies as controls for the
purity of the nuclear and cytoplasmic extracts, respectively (Fig. 1E).
Tax was distributed both in the nucleus and in the cytoplasm as
described previously (Lamsoul et al., 2005), whereas the acetylated
form of Tax was predominantly concentrated in the nucleus.
The transcriptional coactivator p300 is involved in Tax acetylation
Since Tax interacts with various acetyltransferases including the
two related transcriptional coactivators p300 and CBP as well as P/CAF
(Harrod et al., 1998; Jiang et al., 1999; Bex et al.,1998; Kwok et al., 1996;
Scoggin et al., 2001), wewonderedwhether one of these enzymes was
responsible for Tax acetylation. 293T cells were cotransfected with
vectors expressing Tax-6His in combination with increasing amounts
of vectors for expression of p300-HA, CBP or Flag-P/CAF. Vectors for
expression of the amino-termini of p300 (Flag-N-p300) or CBP (Flag-
N-CBP), which interact with Tax but are devoid of acetyltransferase
activity, were used as controls. The Tax protein puriﬁed by Ni-NTA
pulldown as described abovewas analyzed by immunoblotting for the
detection of Tax and acetyllysine (Figs. 2A–C).
Tax acetylation was stimulated by overexpression of p300-HA in a
dose-dependent manner. The anti-Tax immunoblot in Fig. 2A
indicated that the increase in the pool of acetylated Tax did not result
from an increase in the total Tax pool. By contrast, there was no
increase in Tax acetylation when p300 was deleted of its acetyl-
transferase domain (Flag-N-p300), or when CBP (Fig. 2B) or Flag-P/
CAF (Fig. 2C) were expressed, and the intensity of the acetylated form
of Tax was identical in cells expressing full length CBP or just its
acetyltransferase-deﬁcient amino-terminus Flag-N-CBP. Total extracts
were analyzed by immunoblotting with an anti-HA antibody for the
detection of p300-HA, with an anti-CBP or with an anti-Flag antibody
for the detection of Flag-P/CAF, Flag-N-p300 or Flag-N-CBP, assessing
the expression of these various full length or truncated proteins. The
biological activity of the overexpressed CBP and p300 proteins was
also assessed by demonstrating that they were both able to induce
acetylation of the tumor suppressor p53 (see Supplemental data 1).
Thus, the nuclei of Tax-expressing cells, including HTLV-1 transformed
T-lymphocytes, contained a form of Tax which was acetylated in vivo
by the transcriptional coactivator p300, but not by the other Tax-
interacting acetyltransferases CBP or P/CAF.
At this point it was important to demonstrate that the defect of
acetylation of the Tax K10R mutant was not simply the result of its
inability to interact with p300. To this aim, extracts from 293T cells
coexpressing p300-HA and either wild type Tax or the K10R mutant
were co-immunoprecipitated with the anti-Tax antibody in conditions
that preserved protein interactions and the immunoprecipitated
complexes were immunoblotted with the anti-HA antibody to detect
the presence of p300-HA in these complexes (Fig. 2D). These results
indicated that the K10R mutant interacted with p300 like wild type
Tax supporting the idea that lysine K10 was the target for Tax
acetylation.We then analyzed the relative intracellular localizations of
endogenous p300 and either WT Tax or the K10R mutant. Since the
concentration of both p300 and the RelA subunit of NF-κB in Tax
nuclear bodies are properties critical for Tax-mediated activation of
the NF-κB pathway (Bex et al., 1997, 1998), we simultaneously
analyzed the intracellular localization of these proteins by tripleimmunoﬂuorescence staining with anti-Tax, anti-RelA and anti-p300
antibodies followed by confocal microscopy (Fig. 2E). In HeLa cells that
did not express Tax, p300 was predominantly localized in the nucleus,
whereas RelA was only detected in the cytoplasm. Expression of Tax
led to the formation of nuclear bodies and the recruitment of p300 and
RelA in these structures, as previously demonstrated. Mutant K10R
had a distribution very similar to that of wild type Tax and this mutant
also induced the relocalization of RelA from the cytoplasm to the
nucleus and the recruitment of both p300 and RelA in the nuclear
bodies. These results indicated that the defect of acetylation did not
affect Tax intracellular localization and its capacity to recruit p300 and
RelA in the Tax nuclear bodies. They also suggested that cytoplasmic
events leading to RelAmigration to the nucleus including IKK complex
activation and IκBα degradation were not affected by the K10R
mutation. Finally, the fact that both p300 and the acetylated form of
Tax localized predominantly in the nucleus, strongly suggested that
acetylation of Tax by p300 occurred in the nucleus.
Phosphorylation is a prerequisite for Tax acetylation
We then tested whether phosphorylation, ubiquitination or
sumoylation affected Tax acetylation. First, we assessed the effect of
phosphorylation at serine residues 300/301 on Tax acetylation. For
this purpose, we analyzed the acetylation status of two previously
described Tax mutants, including the phosphorylation deﬁcient F2
mutant (S300L, S301A), which is unable to activate gene expression
via both the ATF/CREB and NF-κB pathways, and the phosphomimetic
F9 mutant (S300D, S301D), in which substitution of the serine
residues critical for phosphorylation by phosphomimetic aspartic
acid residues partly restored transcriptional activities. The schematic
representation of these mutants and their transcriptional activities as
described in (Bex et al., 1999) are reported in Fig. 3A. 293T cells were
transfected with vectors expressing wild type Tax-6His or the F2–6His
or F9–6His mutants. The proteins were subjected to Ni-NTA pulldown
and the puriﬁed proteins were analyzed by immunoblotting with
antibodies directed against Tax or acetyllysine (Fig 3B). The phosphor-
ylation deﬁcient F2 mutant was not acetylated, whereas the
phosphomimetic mutant F9 was acetylated like wild type Tax. Thus
a positive correlation was observed between Tax phosphorylation at
serine 300/301 and acetylation at lysine 346.
P300 is localized in the nucleus and acetylation of Tax most likely
occurs in the nucleus. It was thus important to test whether mutant F2
was able to translocate to the nucleus. 293T cells transfected with
vectors expressing the F2 or F9 mutants were analyzed by dual
immunoﬂuorescence staining for the detection of Tax and endogenous
p300 (Fig. 3C). Contrary towhatwas observed forwild type Tax (Fig. 2E),
the anti-Tax immunoﬂuorescence staining was only detected in the
cytoplasm of the majority of the cells expressing mutant F2, and this
mutant did not colocalize with p300, which was only detected in the
nuclei, whereas the phosphomimetic F9mutantwas present both in the
cytoplasm and in the nucleus, in which it displayed a speckled
distribution with p300. We concluded that the inability of the
phosphorylation deﬁcient F2 mutant to be acetylated correlated with
its inability tomigrate to the nucleus and consequently, to meet p300 in
the cells. In support to this conclusion, no in vivo complexes between
mutant F2 and p300 were detected by in vivo pulldown assays of 293T,
coexpressing mutant F2 and p300-HA with the anti-Tax antibody
whereas the phosphomimetic F9mutant formed stable complexes with
p300 likewild type Tax (Fig. 3D). Thus, the presence of negative charges
provided either byphosphoserineorbyaspartic acid residues atposition
300 and 301 correlated with the presence of Tax in the nucleus, its
colocalization in nuclear bodies with p300, the formation of in vivo
complexes with p300 and Tax acetylation. These results suggested that
phosphorylation at serine 300 or 301 indirectly controlled Tax
acetylation by promoting its presence in the nucleus in which Tax/
p300 complexes proﬁcient for acetylation could be assembled.
Fig. 2. The transcriptional coactivator p300 is involved in Tax acetylation. 293T cells were cotransfected with a vector expressing Tax-6His (2 μg) in combination with increasing
amounts of either (A) a vector expressing p300-HA (0, 0.5 and 1 μg) or Flag-N-p300 (0.5 μg), or (B) a vector expressing CBP (0, 0.5 and 1 μg) or Flag-N-CBP (0.5 μg), or (C) a vector
expressing Flag-P/CAF (0, 0.5 and 1 μg). The proteins were puriﬁed by Ni-NTA pulldown and immunoblotted with anti-Tax or anti-acetyllysine antibodies. Total extracts were
immunoblotted with antibodies directed against HA for the detection of p300-HA, against CBP or against Flag for the detection of Flag-N-p300, Flag-N-CBP or Flag-P/CAF. (D) 293T
cells were cotransfected with vectors expressing wild type Tax or the K10Rmutant in combinationwith a vector expressing p300-HA. Extracts were immunoprecipitated (IP) with an
anti-Tax monoclonal antibody, and the puriﬁed complexes were immunoblotted (IB) with the anti-HA antibody for the detection of p300-HA. The whole cell extracts (WCE: 1/50 of
the input) were immunoblotted with antibodies directed against HA or Tax. The numbers under the blot represent the percentages of p300-HA retained in the complexes, calculated
by quantitating the p300-HA species present in the immunoprecipitated complexes after subtraction of the background and normalization for equal amount of p300-HA and Tax in
the whole cell extracts. (E) HeLa cells transfected with either an empty vector or vectors expressing wild type Tax or the K10R mutant for 30 h were stained by triple
immunoﬂuorescence with an anti-Tax monoclonal IgG2a antibody, an anti-RelA rabbit polyclonal serum and an anti-p300 monoclonal IgG1 antibody and analyzed by laser scanning
confocal microscopy.
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simply resulted from a reduced level of phosphorylation, we analyzed
the phosphorylation status of this mutant. 293T cells transfected with
vectors expressing wild type Tax or the K10Rmutant were cultured in
medium containing either [35S] methionine and [35S] cysteine or [32P]
orthophosphate. The F2 mutant was included in this study as anegative control for phosphorylation. The Tax proteins were immu-
noprecipitated with a monoclonal antibody directed against Tax and
analyzed by autoradiography (Fig. 3E). Contrary to the F2 mutant and
as expected from its ability to migrate to the nucleus (Fig. 2E), mutant
K10R displayed 35S and 32P labelled species of intensities similar to
wild type Tax. From these results we concluded that acetylation did
Fig. 3. Phosphorylation is a prerequisite for Tax acetylation. (A) Schematic representation of the phosphorylation defective F2mutant and the phosphomimetic F9mutant with their
ability to activate gene expression via the ATF/CREB and NF-κB pathways as determined in (Bex et al., 1999). (B) 293T cells were transfected with vectors expressing 6His-tagged wild
type Tax or mutants F2 or F9 and the proteins were puriﬁed by Ni-NTA pulldown and immunoblotted with anti-Tax and anti-acetyllysine antibodies. (C) 293T cells were transfected
with vectors expressing the Tax mutants F2 or F9. The cells were stained by dual immunoﬂuorescence with an anti-Tax monoclonal IgG2a antibody and an anti-p300 monoclonal
IgG1 antibody and analyzed by confocal microscopy. (D) 293T cells were cotransfected with vectors expressing wild type Tax or the F2 or F9 mutants in combination with a vector
expressing p300-HA. Extracts were immunoprecipitated with an anti-Tax monoclonal antibody and the puriﬁed complexes were immunoblotted with an anti-HA antibody for the
detection of p300-HA. The whole cell extracts WCE (1/50 of the input) were analyzed by immunoblotting with anti-Tax or anti-HA antibodies. Quantitation was performed as
described in Fig. 2D. (E) 293T cells were transfected with an empty vector or vectors expressing wild-type Tax or the K10R or F2mutants and metabolically labelled with either [35S]
methionine and [35S] cysteine or [32P] orthophosphate. The cell extracts were immunoprecipitated with a monoclonal antibody directed against Tax and analyzed by electrophoresis
on SDS-Page followed by autoradiography.
72 J. Lodewick et al. / Virology 386 (2009) 68–78not control Tax phosphorylation, but that, inversely, phosphorylation
was a prerequisite for Tax acetylation.
Sumoylation improves Tax acetylation
Since formation of the Tax nuclear bodies in which Tax colocalizes
with p300 critically depends on Tax sumoylation, we investigated the
effect of sumoylation on Tax acetylation. To this end, we analyzed the
acetylation status of sumoylation and/or ubiquitination deﬁcient Tax
mutants, including mutant K4–8R, which is neither ubiquitinated nor
sumoylated as a result of the mutation of the ﬁve central lysine
residues, mutant R4–6K, in which reintroduction of lysines K4, K5 and
K6 in the context of the K4–8R mutant partly restored ubiquitination
but not sumoylation and mutant R7–8K, in which reintroduction of
lysines K7 and K8 restored both ubiquitination and sumoylation. The
schematic representation of these mutants and their ubiquitination
and sumoylation status as described in (Lamsoul et al., 2005) are
reported in Fig. 4A. First, co-immunoprecipitation studies indicated
that these lysine mutants interacted with p300 like wild type Tax,
indicating that ubiquitination or sumoylation were not required for
Tax interaction with p300 (Fig. 4B). Interestingly, Ni-NTA pulldown
assays (Fig. 4C) indicated that the non-ubiquitinated and non-
sumoylated mutant K4–8R and the ubiquitinated but non-sumoylated
R4–6Kmutants were poorly acetylated (11% and 26% relatively to wild
type Tax, respectively), whereas the lysine restoration mutant R7–8K,
which was fully ubiquitinated and sumoylated, nearly recovered wild
type level of acetylation (78% relatively to wild type Tax). Weconcluded that sumoylation, and to a lesser extent ubiquitination,
favored acetylation of Tax without affecting its ability to interact
with p300.
To better understand the role of sumoylation in Tax acetylation, we
asked whether the recruitment of p300 in the nuclear bodies
assembled by sumoylated Tax molecules correlated with increased
Tax acetylation. We analyzed the relative intracellular localizations of
endogenous p300 and wild type Tax or Tax mutants deﬁcient for
sumoylation (K4–8R and R4–6K) as well as the sumoylation restora-
tionmutant R7–8K by dual immunoﬂuorescence staining and confocal
microscopy, including the fraction of the Tax-expressing cells which
displayed Tax nuclear bodies (NB) (Fig. 4D). Wild type Tax was present
in discrete nuclear foci in 82% of the Tax-expressing cells and
endogenous p300 was concentrated in the Tax nuclear foci as
previously demonstrated ((Bex et al., 1998) and see above). Mutant
K4–8R, which was neither ubiquitinated nor sumoylated and mutant
R4–6K, which was ubiquitinated but not sumoylated, had a diffuse
distribution in the cytoplasm and the nucleus without formation of
nuclear bodies and p300 had a speckled distribution in the nucleus
like observed in cells that did not express Tax. Both of these mutants
were poorly acetylated (Fig. 4C). Importantly, restoration of sumoyla-
tion by the reintroduction of lysines K7 and K8 (mutant R7–8K)
restored the formation of nuclear bodies inwhich p300was present in
84% of the Tax-expressing cells and improved the acetylation status to
78%. Thus, a positive correlation was observed between the sumoyla-
tion status of Tax mutants, their ability to colocalize with p300 in
nuclear bodies and their level of acetylation.
Fig. 4. Sumoylation improves Tax acetylation. (A) Schematic representation of the Tax protein with the positions of the lysine residues replaced by arginines in the different Tax
mutants. The ubiquitination and sumoylation status of these mutants as determined in (Lamsoul et al., 2005) are indicated. (B) 293T cells were cotransfected with vectors expressing
wild type Tax or the K4–8R or R7–8K mutants in combination with a vector expressing p300-HA. Extracts were immunoprecipitated with an antibody directed against Tax, and the
puriﬁed complexes were immunoblotted with an anti-HA antibody for the detection of p300-HA. The whole cell extracts WCE (1/50 of the input) were analyzed by immunoblotting
with anti-Tax or anti-HA antibodies. Quantitation of immunoprecipitated p300-HA was performed as described in Fig. 2D. (C) 293T cells were transfected with vectors expressing
wild type or mutant Tax-6His as indicated. The cell extracts were puriﬁed by Ni-NTA pulldown followed by immunoblotting with anti-Tax or anti-acetyllysine antibodies. The
numbers under the blot represent the percentages of acetylated forms for each mutant relatively to wild type Tax, calculated after subtraction of the background on the α-Ac
immunoblot and normalization to equal amount of the 40 kDa Tax species on the α-Tax immunoblot. (D) 293T cells were transfected with vectors expressing wild type Tax or the Tax
mutants as indicated. The cells were stained by dual immunoﬂuorescence with an anti-Tax monoclonal IgG2a antibody and an anti-p300monoclonal IgG1 antibody. The percentages
of cells displaying Tax-containing nuclear bodies (NB) are indicated. (E) 293T cells were transfected with vectors expressing Tax or the Tax–SUMO-1 fusionwere submitted to Ni-NTA
pulldown followed by immunoblotting with anti-Tax or anti-acetyllysine antibodies.
73J. Lodewick et al. / Virology 386 (2009) 68–78It was thus critical to determine whether sumoylated Tax
molecules could be acetylated. To this end, we analyzed the
acetylation status of a Tax–SUMO-1 fusion in which SUMO-1 was
fused in frame to the carboxy-terminus of Tax. This fusion was
previously shown to assemble nuclear bodies in 100% of Taxexpressing cells (Lamsoul et al., 2005) and to recruit p300 in these
nuclear structures (data not shown). Fig. 4E demonstrates that the
constitutively sumoylated Tax–SUMO-1 fusion was acetylated.
Furthermore, quantitation of the acetylated forms of Tax and Tax–
SUMO-1 on the anti-acetyllysine immunoblot and normalization to
74 J. Lodewick et al. / Virology 386 (2009) 68–78equal amounts on the anti-Tax immunoblot indicated that the Tax–
SUMO-1 fusion was more acetylated (181%) than non-fused Tax. This
observation supports the idea that sumoylation stimulates Tax
acetylation.
Acetylation differentially affects Tax-mediated activation of gene
expression via ATF/CREB and NF-κB pathways on promoters integrated
in the chromatin
We then analyzed the functional consequences of Tax acetylation.
To this aim, we introduced the K10R mutation in the background of a
cloned HTLV-1 provirus (ACH K10R) and we compared the kinetics of
virus production in the culture supernatants of HeLa cells transfected
with the cloned ACH WT and ACH K10R proviruses (Fig. 5A). The
analysis of the supernatants by an ELISA using a monoclonal antibody
directed against the HTLV-1 matrix protein p19 indicated that virus
production followed similar kinetics in both cultures, suggesting that
the wild type and K10R Tax proteins produced by the two proviruses
had comparable abilities to activate transcription from the HTLV-1
promoter.
We then tested the consequences of acetylation on Tax transcrip-
tional activities. 293T cells were transfected for two days with the
cloned ACH WT or K10R proviruses, in combination with luciferase
reporter constructs under the promoter present in the HTLV-1-LTR
(HTLV-LTR-Luc) for the analysis of the ability of Tax to activate gene
expression via the ATF/CREB pathway or under the control of the
promoter present in the HIV-1-LTR (HIV-LTR-Luc), which contains two
NF-κB binding sites, for the analysis of the ability of Tax to activate
gene expression via the NF-κB pathway (Fig. 5B). ACH K10R was
able to activate gene expression from the transiently transfected
ATF/CREB- or NF-κB-controlled promoters at levels comparable
(102%+/−13 and 93%+/−4, respectively) to wild type ACH.
Tax activation of gene expression has a more stringent dependency
on cofactors on integrated promoters than on transiently transfected
promoters (Okada and Jeang, 2002). We thus tested the ability of the
cloned wild type and K10R proviruses to activate transcription from
integrated ATF/CREB- or NF-κB-controlled promoters. The chromatin
of CHOK-1 cells and HeLa 57A cells contains an integrated HTLV-1-
LTR-Luc construct or an integrated κB-ConA-Luc construct, respec-
tively. These cells were transfected for three days with the cloned wild
type or K10R ACH proviruses (Fig. 5C). The ability of the ACH K10R
provirus to activate the integrated NF-κB promoter was reduced by
two fold (42%+/−12%) relatively to the wild type ACH, whereas
activation of the integrated HTLV-1-Luc reporter genewas not affected
(101%+/−14 relatively to wild type ACH). This effect was not the result
of a reduced expression of Tax K10Rmutant by the K10R ACH provirus
since both proviruses produced equal amounts of Tax.
To convincingly demonstrate that the reduced level of activation of
the NF-κB pathway by ACH K10R was the results of the defect of Tax
acetylation, we tested whether overexpression of p300 could enhance
the transcriptional activity of ACHWT, but not the activity of ACHK10R.
HeLa 57A cells were cotransfected for three days with either the wild
type or the K10R proviruses and increasing amounts of the vector
expressing p300-HA (Fig. 5D). Overexpression of p300 increased the
ability of ACH WT to activate expression from the integrated NF-κB-
controlled promoter in a dose-dependent manner. By contrast, no
increase in luciferase activity was observed in HeLa 57A cells
coexpressing the K10R provirus and p300. These results indicated
that overexpression of p300, resulting in increased acetylation of Tax
(Fig. 2A), markedly stimulated activation of gene expression from an
integrated NF-κB-controlled promoter and this effect was speciﬁc
since the defect of acetylation had no consequence on the activation of
gene expression via the ATF/CREB pathway. These results also suggest
that Tax is poorly acetylated when expressed in HeLa cells unless p300
is overexpressed since expression of wild type Tax only increased by a
factor two activation of gene expression from the integrated NF-κB-controlled promoter as compared to the acetylation deﬁcient mutant
K10R (Fig. 5C), whereas the effect was much more dramatic (3.5 fold
increase) when wild type Tax was coexpressed with p300 (Fig. 5D).
Discussion
In this work, we establish that the Tax oncoprotein of HTLV-1 is
acetylated in cells expressing Tax as well as in HTLV-1 transformed
T-lymphocytes. This modiﬁcation targets lysine residue K10 at amino
acid position 346 in the carboxy-terminus of Tax, involves the
acetyltransferase activity of the transcriptional coactivator p300, and
most likely occurs in the nucleus since Tax acetylation depends on its
presence in the nucleus and both p300 and the acetylated form of Tax
are localized in the nucleus. Our results indicated that Tax acetylation
promoted activation of gene expression from a NF-κB-controlled
promoter integrated in the chromatin. This was evidenced by the facts
that this phenotype was altered in cells transfected with the provirus
producing the acetylation deﬁcient K10R mutant Tax and that
increased acetylation of Tax following over-expression of p300
promoted the activation of an integrated NF-κB-controlled promoter
by a wild type HTLV-1 provirus but not by the K10R mutant provirus.
Acetylation and the subsequent control NF-κB activation is the third
phenotype to be attributed to the 13 carboxy-terminal amino-acids of
Tax. Besides the lysine K346, this region also includes amotif involved in
the interaction of Tax with PDZ-domain proteins (Rousset et al., 1998)
and a domain involved in the formation of micronuclei (Semmes et al.,
1996). Moreover, these 13 carboxy-terminal amino acids are highly
divergent in the less pathogenic but otherwise highly related Tax
proteins of the various HTLV-2 isolates (Tax-2), resulting in the inability
of Tax-2 to interactwith PDZ-domainproteins (Hirata et al., 2004) and to
induce the formation of micronuclei (Semmes et al., 1996). Our recent
results indicate that the Tax-2 protein of the HTLV-2B isolate is
acetylated (Supplemental data 2). It will be critical to determine
whether acetylation is involved in the oncogenic potential of Tax.
Our previous studies indicated that Tax-mediated activation of the
NF-κB pathway requires both cytoplasmic and nuclear events,
including the release of RelA cytoplasmic sequestration by ubiquiti-
nated Tax molecules and the recruitment of RelA in Tax nuclear bodies
by sumoylated Tax molecules (Lamsoul et al., 2005). These two steps
were carried out by the acetylation deﬁcient mutant K10R, which had
wild type abilities to be ubiquitinated and sumoylated, to induce
translocation of RelA to the nucleus and to colocalize with RelA and
p300 in nuclear bodies. Thus, the transcriptional activity of Tax on an
integrated NF-κB-controlled promoter was promoted by Tax acetyla-
tion but this step was dispensable for the activation of a transiently
transfected promoter. Interestingly, the acetylation deﬁcient K10R Tax
mutant stimulated virus production and activated the HTLV-1
promoter as efﬁciently as wild type Tax.
Tax interacts directly with the two related transcriptional coacti-
vators p300 and CBP and the acetyltransferase activity of these
coactivators leading to acetylation of histone tails is critical for
activation of the HTLV-1 promoter on chromatin templates (Georges
et al., 2002; Lu et al., 2002). Here we show that p300, but not CBP,
acetylates Tax in vivo, which speciﬁcally promotes activation of gene
expression from an integrated NF-κB-controlled promoter. This
observation suggests that acetylation of Tax may affect the stability
or the chromatin-remodelling activity of transcription complexes on
an integrated NF-κB-controlled promoter. It is important to note that
the acetyltransferase activities of the highly related CBP and p300 not
only depend on phosphorylation events by speciﬁc kinases that target
non-conserved serine residues of CBP and p300 but that these two
transcriptional coactivators display non overlapping activities (Turnell
and Mymryk, 2006; Kalkhoven, 2004), which is supported by the fact
that p300−/−

or CBP−/− knockout mice have different phenotypes (Kung
et al., 2000; Yao et al.,1998). Support in favor of the speciﬁc role of p300
in Tax acetylation would require knock-down of p300 or CBP.
Fig. 5. Acetylation differentially affects Tax-mediated activation of gene expression via ATF/CREB and NF-κB pathways on promoters integrated in the chromatin. (A) The supernatants
of HeLa 57A cells transfected with the wild type or K10R proviruses were collected at various time points after transfection and analyzed by ELISA with a monoclonal antibody
directed against the HTLV-1 matrix protein p19 for the quantitation of virus production. (B) 293T cells were cotransfected for two days with either the HTLV-1 LTR-Luc (ATF/CREB) or
the HIV-1 LTR-Luc (NF-κB) reporter plasmids and the vectors carrying either the cloned wild type HTLV-1 provirus (white bars) or the mutated K10R provirus (black bars). ACH WT
activated gene expression from the transiently transfected HTLV-1 LTR and HIV-1 LTR 26+/−6 and 12+/−1 fold, respectively. (C) CHOK-1 cells, which contain an HTLV-1 LTR-Luc
reporter construct integrated in the chromatin (ATF/CREB) or HeLa 57A cells with an integrated κB-ConA-Luc reporter construct (NF-κB) were transfected for 3 days with the vectors
carrying either the cloned wild type HTLV-1 provirus (white bars) or the mutated K10R provirus (black bars). ACHWT activated gene expression from the integrated HTLV-1 LTR and
NF-κB-controlled promoters 25+/−3 and 44+/−7 fold, respectively. (D) HeLa 57A cells were cotransfected with the ACHWTor ACH K10R proviruses (100 ng) and increasing amounts
of the vector for expression of p300-HA (0, 50, 100, 200, 400 and 800 ng). The values are averages from at least six independent experiments, with the standard deviations indicated.
75J. Lodewick et al. / Virology 386 (2009) 68–78Both phosphorylation of Tax at serine residues 300/301 and
sumoylation at lysine residues 280/284 correlated with increased
acetylation of Tax. Contrary to the phosphorylation deﬁcient F2mutant,
the phosphomimetic F9mutantwas found in the nuclei and thismutant
was acetylated likewild type Tax, indicating that the translocation of Tax
to the nucleus conditioned Tax acetylation. Contrary to the correlation
observed between the inability of the phosphorylation deﬁcient F2
mutant to form complexes with p300 in vivo and its lack of acetylation,
sumoylation deﬁcientmutantswere able to interact with p300 likewildtype Tax, but they were nevertheless poorly acetylated. In addition,
restoration of sumoylation inmutant R7–8K, or fusion of SUMO-1 to the
carboxy-terminus of Tax, which favored formation of Tax nuclear bodies
that included p300, signiﬁcantly increased Tax acetylation. Because the
acetyltransferase activity of p300 is induced by phosphorylation events
involving speciﬁc kinases such as AKTor HIPK2 (Huang and Chen, 2005;
Huang et al., 2007), we hypothesize that nuclear bodies containing Tax
and p300 also recruit a kinase involved in the activation of p300
acetyltransferase activity.
76 J. Lodewick et al. / Virology 386 (2009) 68–78We conclude that the ability of Tax to constitutively activate the NF-
κB pathway critically depends on a hierarchical sequence of post-
translationalmodiﬁcationswhichdifferentially controls Tax intracellular
localization and its transcriptional activity. Considering the role of
acetylated Tax in promoting activation of the NF-κB pathway and the
critical role of this pathway in Tax transforming activity, we suggest that
Tax acetylation contributes to HTLV-1-induced leukemias/lymphomas.
Materials and methods
Cell culture and transient expression experiments
293T human embryonic kidney and HeLa human cervical epithelial
carcinoma cell lines, the non-infected CEM and HTLV-1 transformed
C8166 and HUT102 T-lymphocyte cell lines were obtained from the
ATCC or ECACC (CRL-11268, CCL-2, CRL-1991, 88051601, TIB-162). The
CHOK-1 cells, which contain a HTLV-1-LTR-Luc construct integrated in
the chromatin, and HeLa 57A cells, which contain an integrated NF-κB-
Luc construct (3Enhancer-κB-ConA-Luc), were kindly provided by J.
Nyborg (Lemasson et al., 2006) and R. Hay (Rodriguez et al., 1999),
respectively. The 293T, CHOK-1, HeLa 57A and HeLa cells were
maintained in Dulbecco's modiﬁed Eagle's medium supplemented
with 10% foetal calf serum, 2 mM L-glutamine, 1% penicillin–strepto-
mycin, and 1 mM sodium pyruvate (Gibco), with the addition of 500 μg
of G418 per ml (Calbiochem) for cultures of CHOK-1 and HeLa 57A cells.
The T-lymphocyte cell lines CEM, C8166 and HUT102 were maintained
in RPMI 1640mediumwith Glutamax-I (Gibco) supplementedwith 10%
foetal calf serum. 293T cells were transfected using FuGENE 6 reagent
(Roche) according to the manufacturer's instructions. The CEM T-
lymphocyte cell line was transfected by electroporation with a Gene
Pulser electroporator (Bio-Rad Laboratories).
Plasmid constructs
The vectors for expression of wild type Tax-6His or lysine to
arginine substitution mutants or the Tax–SUMO-1 fusion and the
vectors for expression of ubiquitin or SUMO-1 fused at their amino-
termini to the inﬂuenza virus hemagglutinin epitope (HA-Ub and HA-
SUMO-1) were described in (Lamsoul et al., 2005). Three additional
mutants, K9R, K10R and K9–10R, were generated by PCR based site-
directed mutagenesis (Quick Change kit, Stratagene). The vectors for
expression of CBP (Kwok et al., 1994), p300-HA (Hanstein et al., 1996)
and Flag-P/CAF (Yang et al., 1996) have been previously described. The
vectors for expression of Flag-N-p300 and Flag-N-CBP were con-
structed by PCR ampliﬁcation of the sequence coding for the amino-
termini of p300 (amino acids 1 to 595) or CBP (amino acids 1 to 616)
and cloning of the ampliﬁed fragments in vector pJFE14 (Takebe et al.,
1988). The cloned HTLV-1 provirus ACH was kindly provided by L.
Ratner (Kimata et al., 1994). The ACH K10R mutant provirus was
constructed ﬁrst by replacing the unique SacI–SmaI fragment contain-
ing the 3′ end of the tax gene in the wild type ACH provirus deleted of
the KpnI fragment, by the PCR ampliﬁed SacI–SmaI fragment
containing the K10R mutation and then by transferring the unique
NsiI–EcoRI fragment containing the mutated K10R tax gene in the full
length wild type provirus. Sequencing was used to check for the
presence of the K10R mutation and for the correct nucleotide
sequence. The K10 codon AAA at nucleotide position 1036 to 1038
in the Tax coding sequence was replaced by the arginine codon CGC.
These changes do not affect the coding sequence of other HTLV-1
proteins including Rex or HBZ.
Antibodies
The rabbit polyclonal antibodies directed against HA (Y-11), CBP
(A-22) and RelA (C-20), the goat polyclonal antibodies directed against
IKKβ (T-20) and hnRNP A1 (Y-15) were purchased from Santa CruzBiotechnology. The anti-Flag monoclonal IgG1 antibody (M2) was
from Sigma, the anti-acetyllysine monoclonal IgG1 antibody was from
Cell Signaling Technology and the anti-p300 monoclonal IgG1 anti-
body (RW-128) was fromUpstate. Tax proteins were revealed with the
anti-Tax monoclonal antibody from hybridoma 168-A51 (AIDS
Research and Reagent Program, National Institutes of Health) or a
polyclonal serum obtained by immunizing rabbits with a puriﬁed
maltose binding protein–Tax fusion produced in bacteria. For
quantitation of virus production, cell-free supernatants collected at
different time points after transfection were analyzed by Enzyme
Linked Immunosorbent Assay (ELISA) using the RetroTek HTLV-I/II p19
Antigen ELISA kit (ZeptoMetrix Corp.) according to the manufacturer's
instructions. The concentration of HTLV-1 p19 in specimens was
determined by interpolation from a standard curve.
Ni-NTA pulldown assays
293T or CEM T-cells expressing wild type or mutant Tax-6His were
lysed 30 h and 48 h after transfection, respectively, and Ni-nitrilotria-
cetic acid (NTA) pulldown assays were done as described in (Lamsoul et
al., 2005). Brieﬂy, cell pellets were lysed under reducing and highly
denaturing conditions using buffer A (6 M guanidinium-HCl, 0.1 M
Na2HPO4–NaH2PO4, 0.01M Tris–HCl, pH 8.0, 5mM imidazole,10mMβ-
mercaptoethanol) and incubatedwithNi2+-NTAbeads for 4 h at 4 °C. The
beadswerewashedwithbuffer A, B (8Murea, 0.1MNa2HPO4–NaH2PO4,
0.01 M Tris–HCl, pH 8.0, 10 mM imidazole, 10 mM β-mercaptoethanol),
andC (8Murea, 0.1MNa2HPO4–NaH2PO4, 0.01MTris–Cl, pH6.3,10mM
imidazole, 10 mM β-mercaptoethanol), and the bound proteins were
eluted with buffer D (300 mM imidazole, 0.15 M Tris–HCI, pH 6.7, 30%
glycerol, 0.72 M β-mercaptoethanol, 5% sodium dodecyl sulfate). All
solutions containeda cocktail of inhibitors, including50mMNaF, 20mM
β-glycerophosphate, 1 mM orthovanadate, 50 mM N-ethylmaleimide,
0.5 μM trichostatin A (TSA), 5 mM nicotinamide, and the protease
inhibitor cocktail (Roche). To detect modiﬁed forms of endogenous Tax
in HTLV-1 transformed T-lymphocytes cell lines C8166 and HUT102,
cells were lysed for 20 min in buffer A. The lysates were precipitated for
10 min in ice in 10% trichloroacetic acid. The puriﬁed proteins were
submitted to electrophoresis on 4 to 12% bis-Tris NuPAGE gel
(Invitrogen), transferred to a Hybond enhanced-chemiluminescence
nitrocellulose membrane (Amersham Pharmacia Biotech), and immu-
noblotted with the primary antibodies and corresponding secondary
antibodies conjugated to horseradish peroxidase. The detection was
performed using the ECL Advance Western blotting detection kit
(Amersham) and quantitation of chemiluminescent signals was per-
formed with the Chemi-Smart 5000 apparatus and Bio-1D software
(Vilber Lourmat, France).
Cell fractionation
293T cells expressing Tax-6His were washed in Tp I (20 mM Hepes
buffer pH 7.9, 2 mMMgCl2, 1 mM dithiothreitol) containing inhibitors
as above and then lysed on ice for 10 min in the same buffer
containing 0.2% NP40. The samples were centrifuged to collect the
cytoplasmic components. The resulting pellet containing the nuclear
fraction was lysed in Tp II (Tp I supplemented with 420 mM KCl, 25%
glycerol and 1 mM EDTA) on ice for 20 min and centrifuged for 10 min
to collect the nuclear fraction. Finally, each cytoplasmic or nuclear
fractionwas submitted to Ni-NTA pulldown assays as described above.
Immunocytochemistry and confocal microscopy
Cells cultured on glass coverslips were ﬁxed with Immunohistoﬁx
(A phase Inc., Belgium), an aldehyde-free zinc ﬁxative, to stabilize
cellular structures for 10 min at room temperature (Pajak et al., 2000)
followed by incubation in 100%methanol at −20 °C for 6 min. The cells
were washed with PBS (phosphate buffered saline), blocked in PBS
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(Gibco), and incubated with the primary antibodies diluted in the
blocking solution. The preparations were then washed with PBS
containing 0.2% gelatin and incubated with the secondary antibodies,
goat anti-rabbit immunoglobulin G (IgG) conjugated to Alexa Fluor
546, goat anti-mouse total IgG or IgG2a conjugated to Alexa Fluor 488
or goat anti-mouse IgG1 coupled to biotin (Southern Biotechnology
Associates, Ala.) for dual- or triple- immunoﬂuorescence staining.
Samples were washed and, when biotinylated goat anti-mouse IgG1
was used as the secondary antibody, cells were incubated for 20 min
with Cy5-conjugated streptavidin (Jackson ImmunoResearch). Con-
trols to test for secondary antibodies cross-reaction demonstrated the
desired speciﬁcity of the ﬂuorescent reagents. Samples were then
mounted in DABCO based medium and analyzed with a laser scanning
confocal microscope (LSM510; Zeiss) using a 63× objective and light
source wavelengths of 488, 543 and 633 nm.
In vivo incorporation of 32P-orthophosphate or 35S-labeled methionine
and cysteine
293T cells were transfected with vectors expressing wild type or
mutant Tax for 24 h. Cells were washed twice with PBS and incubated
in starvation medium (minimal Eagle medium without methionine
and cysteine or without phosphate) for 30 min which was then
replaced by the same medium containing either 100 μCi of [35S]
methionine and [35S] cysteine (ICN) or 0.5 mCi of [32P] orthopho-
sphate (ICN). The labelling was continued for 1 h at 37 °C. The cells
were then washed twice with PBS, and lysed with RIPA buffer (Tris–
HCl 50 mM pH 8.0, NaCl 150 mM,1% Nonidet P-40, 0.5% deoxycholate,
0.1% SDS). The Tax protein was immunoprecipitated with an anti-Tax
monoclonal antibody, submitted to electrophoresis on a 10% SDS page
gels and analyzed by autoradiography.
In vivo coimmunoprecipitation
293T cells were cotransfected with vectors for expression of wild
type or mutant Tax and a plasmid expressing p300-HA. 24 h after
transfection, cells were washed with 1 ml of ice cold PBS containing
1 mM PMSF, 50 mM NaF, 20 mM β-glycerophosphate and lysed for
20 min on ice in lysis buffer (25 mM Tris–HCl, pH 7.4, 150 mM NaCl,
1 mM EDTA, 1% NP-40, 1 mM PMSF, 50 mM NaF, 20 mM β-
glycerophosphate, 0.5 μM TSA and 5 mM nicotinamide). Cell extracts
were then immunoprecipitated with an anti-Taxmonoclonal antibody
using gamma-bind plus sepharose (Amersham Biosciences). The
beads were washed with lysis buffer four times and eluted in SDS-
PAGE loading buffer. The immunoprecipitated proteins were analyzed
by immunoblotting and quantitation of the chemiluminescent signals
was performed as described above.
Luciferase assays
Tax-mediated transactivation of the transiently transfected HTLV-1
and HIV-1 promoters via the activating transcription factor (ATF)/
CREB and NF-κB pathways, respectively, was assayed by dual-
luciferase assays. 293T (1.25×105 cells) were transfected into 12-
well plates with 100 ng of phRG-TK (Promega), which was used for
monitoring transfection efﬁciency, 500 ng of HTLV-1-LTR- or HIV-1-
LTR-luciferase reporter plasmids, and 500 ng of the vector carrying the
cloned wild type or K10R ACH proviruses. For luciferase assays using
integrated promoters, CHOK-1 or HeLa 57A cells were transfectedwith
100 ng of phRG-TK and 500 ng of the wild type or K10R mutant
proviruses alone or in combination with increasing amounts of the
vector coding for p300-HA (50, 100, 200, 400 and 800 ng). Total
amounts of DNA were equalized by adding the empty vector into the
transfection mixture. Cells were lysed and subjected to luciferase
assay with a TD-20/20 luminometer (Turner Designs) using the dual-luciferase reporter assay system (Promega). The results represent the
averages and the standard deviations of at least six independent
experiments.
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